The pharmaceutical industry engages in the research, development, production and sale of chemical products or bio-drugs used for disease prevention or treatment. Drugs, vaccines and antiserums, vitamins, pharmaceutical preparations for veterinary use, and other products comprise the industry.
It is estimated that the industry in Mexico produced 10.129 billion dollars in 2015.
In 2015, Mexican pharmaceutical exports reached 1.855 billion dollars, making Mexico the leading exporter in Latin America.
The main export destinations were the Switzerland, United States and Panama, with shares in total Mexican exports from the industry of 24%, 18% and 8%, respectively.
Among the products that were exported drugs are alkaloids or its derivatives, medicaments containing antisera and other antibiotics.
According to INEGI, there are 770 economic units in Mexico that specialize in the pharmaceutical industry. They are located mainly in Mexico City, Jalisco, Estado de MÃ©xico, Puebla and Morelos.
Twenty of the 25 top international pharmaceutical companies have presence in Mexico, such as Merck, Boehringer Ingelheim, Schering Plough, Bayer, Astrazeneca, Pfizer, Glaxosmithkline, Baxter, Eli Lilly Company and Novartis.
The pharmaceutical industry recorded an accumulated investment of 2.966 billion dollars in the 2009-2015 period.
•Manufacturing Costs. KPMG's study Competitive Alternatives 2016 shows that Mexico offers savings of 17.1% in manufacturing costs in the pharmaceutical industry compared to the United States.
•Market Size. The Mexican pharmaceutical market is the second largest in Latin America. In 2015 alone, the Mexican population consumed 13.640 billion dollars in pharmaceuticals.
•Regulations. Mexico is one of the most developed markets in Latin America in terms of regulations; the Federal Commission for the Protection Against Health Risks (COFEPRIS) has been recognized by the Pan-American Health Organization as a health regulatory, control and promotion authority in Mexico.
•Export Platform. Mexico's location enables considerable savings in logistics and close monitoring of the manufacturing process, facilitates plant inspection by health authorities and allows rapid response to sudden changes in demand trends.